Jump to:
loading...| Preferred Name |
Teneligliptin |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C87623 |
| CAS_Registry |
760937-92-6 |
| Chemical_Formula |
C22H30N6OS |
| code |
C87623 |
| Concept_In_Subset | |
| Contributing_Source |
FDA |
| DEFINITION |
A long-acting, orally bioavailable, pyrrolidine-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Teneligliptin may also reduce plasma triglyceride levels through a sustained increase in GLP-1 levels. |
| FDA_UNII_Code |
28ZHI4CF9C |
| FULL_SYN |
Teneligliptin TENELIGLIPTIN ((2S,4S)-4-(4-(3-Methyl-1-Phenyl-1H-Pyrazol-5-yl)Piperazin-1-yl)Pyrrolidin-2-yl)(1,3-Thiazolidin-3-yl)Methanone |
| label |
Teneligliptin |
| Preferred_Name |
Teneligliptin |
| prefixIRI |
Thesaurus:C87623 |
| prefLabel |
Teneligliptin |
| Semantic_Type |
Pharmacologic Substance |
| UMLS_CUI |
C2981308 |
| subClassOf |